Two Directors at MongoDB Inc sold 8,805 shares at between 349.170USD and 350.000USD. The significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in Piper Sandler’s 36th Annual Healthcare Conference. TELA’s management is scheduled to present at Piper Sandler’s 36th Annual Healthcare Conference at 12:00 pm ET on December 3rd, 2024. Interested parties can access the live and archived webcast at . About TELA ...
A director at Paycom Software Inc sold 3,900 shares at 229.094USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
TELA Bio Reports Third Quarter 2024 Financial Results Reiterates 2024 Revenue Guidance and Expects Recently Implemented Operational Efficiency Improvements to Reduce Operating Expenses in 2025 MALVERN, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the third quarter ended September 30, 2024. Recent Highlights Reported revenue of $19.0 million in the third quarter, representing growth of 26% over the prior year pe...
The Tile Shop Reports Third Quarter 2024 Results MINNEAPOLIS, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (Nasdaq: TTSH) (the “Company”), a specialty retailer of natural stone, man-made and luxury vinyl tiles, today announced results for its third quarter ended September 30, 2024. Third Quarter 2024 Summary Net Sales Decreased 8.3%Comparable Store Sales Decreased 7.9% Gross Margin of 66.5%Net Income of $41 Thousand and Adjusted EBITDA of $5.0 MillionCompany Remains Bank Debt Free with $25 Million of Cash Management Commentary – Cabell Lolmaugh, CEO “Despite c...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., Nov. 01, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 5,400 shares of its common stock to six newly-hired employees, with a grant date of November 1, 2024 (the "Grant Date"). The restricted stock units were granted purs...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Nuveen Quality Municipal Income Fund and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 28 October 2024 in which we reassessed the appropriateness of the rati...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.